Pharsight Corp.
Mountain View, WI 94041
Share:
Software displays model-based drug compound profile.
Web-based and desktop software tool, Drug Model Explorer (DMXÃ-®) v1.6, allows clinical drug development teams to explore modeled efficacy, safety, and other performance attributes of new drugs versus competing therapies. It supports visualizations of predicted drug performance against user-defined target measures of clinical safety and efficacy, defining product profile. Additional...
Read More »Software orchestrates pharmacokinetic analyses.
Offered as configurable software application for WinNonlin, WinNonlinÃ-® AutoPilot(TM) v1.1 automates production of clinical pharmacokinetic (PK) analyses from study data to be used in standard reports. Infrastructure and tools facilitate common or repetitive data transformations, PK analysis, and creation of report-ready tables and graphs. Software operates with Pharsight's enterprise PK...
Read More »Pharsight Collaborates with LabLogic to Link WinNonlin-®, Debra(TM) Products Enhanced Interoperability Increases Utility of Both Products
MOUNTAIN VIEW, Calif., Sept. 15 // -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services designed to optimize clinical drug development, today announced that it has signed a cooperation agreement with LabLogic Systems Limited to enhance the link between Debra, LabLogic's drug metabolism Laboratory Information Management System, and Pharsight's...
Read More »Software validates clinical data management software.
Pharsight Knowledgebase Server v3.0 Validation Suite(TM) enables rapid and reliable validation of PKS 3.0 installations using combination of automated and manual tests. It provides templates for validation life cycle documents, such as Validation Plan, Test Plan, and Validation Summary Report, and inserts automated test results into Validation Run Report.
Read More »Pharsight to Present at Jesup and Lamont 2008 Emerging Growth Stock Conference
MOUNTAIN VIEW, Calif., Feb. 22 - Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development announced today that it will be presenting at Jesup and Lamont's 2008 Emerging Growth Stock Conference on February 28, 2008 at the Walt Disney Contemporary resort in Orlando, FL. Shawn O'Connor, Pharsight's...
Read More »FDA and Pharsight Continue to Collaborate under CRADA
FDA Modeling and Simulation Infrastructure Now Incorporates Three Pharsight Products MOUNTAIN VIEW, Calif., Dec. 11 / -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today provided an update on its Cooperative Research and Development Agreement (CRADA) with the Food and Drug...
Read More »Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
Dr. Andreas Krause to Present on Statistical Considerations for Model Selection and Bias; Dr. Klaas Prins to Present on Modeling and Simulation Using Metadata MOUNTAIN VIEW, Calif., Sept. 4 -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, today announced that Pharsight senior scientists will deliver...
Read More »Pharsight Invited to Present at the Noble Financial Two Double-O-Seven Conference
MOUNTAIN VIEW, Calif., Aug. 13 / -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, announced today that it will present at the Noble Financial Two-Double-O-Seven Conference in Charleston, South Carolina on Monday, August 20, 2007 at 3:30 p.m. Eastern Time. Management will give a presentation discussing...
Read More »Software displays model-based drug compound profile.
Web-based and desktop software tool, Drug Model Explorer (DMXÃ-®) v1.6, allows clinical drug development teams to explore modeled efficacy, safety, and other performance attributes of new drugs versus competing therapies. It supports visualizations of predicted drug performance against user-defined target measures of clinical safety and efficacy, defining product profile. Additional...
Read More »Software orchestrates pharmacokinetic analyses.
Offered as configurable software application for WinNonlin, WinNonlinÃ-® AutoPilot(TM) v1.1 automates production of clinical pharmacokinetic (PK) analyses from study data to be used in standard reports. Infrastructure and tools facilitate common or repetitive data transformations, PK analysis, and creation of report-ready tables and graphs. Software operates with Pharsight's enterprise PK...
Read More »Pharsight Launches New Client Service Offering, Expands Management Team
Company Hires Jean-Francois Marier, Ph.D., to Lead Reporting and Analysis Services MOUNTAIN VIEW, Calif., May 10 / -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, expanded its management team today by hiring Jean-Francois Marier, Ph.D., to fill the newly-created position of Vice President, Reporting...
Read More »Pharsight's New Internship Program to Support Future Leadership in Modeling and Simulation Discipline
MOUNTAIN VIEW, Calif., Feb. 20: Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, today announced that it has accepted the first intern into a program designed to foster knowledge of modeling and simulation amongst graduate students doing clinical research in a variety of scientific disciplines. The first...
Read More »Pharsight Collaborates with LabLogic to Link WinNonlin-®, Debra(TM) Products Enhanced Interoperability Increases Utility of Both Products
MOUNTAIN VIEW, Calif., Sept. 15 // -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services designed to optimize clinical drug development, today announced that it has signed a cooperation agreement with LabLogic Systems Limited to enhance the link between Debra, LabLogic's drug metabolism Laboratory Information Management System, and Pharsight's...
Read More »Pharsight Expands Japanese Distribution Capability
CTC Laboratory Systems Corporation to Distribute PKS and Trial Simulator in Japan MOUNTAIN VIEW, Calif., June 21 / -- Pharsight Corporation (BULLETIN BOARD: PHST) , a leading provider of software and strategic services for optimizing clinical drug development, announced today that CTC Laboratory Systems Corporation of Tokyo, Japan, will distribute to the Japanese market PharsightÃ-®...
Read More »